Studies of an orally active leukotriene antagonist L-649,923 in normal man. 1987

N C Barnes, and P J Piper, and J F Costello
Department of Thoracic Medicine, King's College School of Medicine and Dentistry, London, England.

UI MeSH Term Description Entries
D008297 Male Males
D010654 Phenylbutyrates Derivatives of 4-phenylbutyric acid, including its salts and esters.
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013189 SRS-A A group of LEUKOTRIENES; (LTC4; LTD4; and LTE4) that is the major mediator of BRONCHOCONSTRICTION; HYPERSENSITIVITY; and other allergic reactions. Earlier studies described a "slow-reacting substance of ANAPHYLAXIS" released from lung by cobra venom or after anaphylactic shock. The relationship between SRS-A leukotrienes was established by UV which showed the presence of the conjugated triene. (From Merck Index, 11th ed) Slow Reacting Substance of Anaphylaxis

Related Publications

N C Barnes, and P J Piper, and J F Costello
February 1989, Journal of cardiovascular pharmacology,
N C Barnes, and P J Piper, and J F Costello
January 1987, Advances in prostaglandin, thromboxane, and leukotriene research,
N C Barnes, and P J Piper, and J F Costello
May 1987, The Journal of allergy and clinical immunology,
N C Barnes, and P J Piper, and J F Costello
January 1987, Advances in prostaglandin, thromboxane, and leukotriene research,
N C Barnes, and P J Piper, and J F Costello
January 1987, Advances in prostaglandin, thromboxane, and leukotriene research,
N C Barnes, and P J Piper, and J F Costello
April 1994, Inflammation,
N C Barnes, and P J Piper, and J F Costello
January 1991, Advances in prostaglandin, thromboxane, and leukotriene research,
Copied contents to your clipboard!